Literature DB >> 23178744

Intact or "active" corticosteroid-binding globulin (CBG) and total CBG in plasma: determination by parallel ELISAs using monoclonal antibodies.

John G Lewis1, Peter A Elder.   

Abstract

The predominant carrier of cortisol in circulation is corticosteroid-binding globulin (CBG) which is a non-functional member of the family of serine protease inhibitors. Corticosteroid-binding globulin possesses an exposed elastase sensitive loop and upon cleavage it adopts a "relaxed" conformation promoting the delivery of cortisol to sites of inflammation. Recently we have developed monoclonal antibodies which recognise only the intact exposed elastase loop, including an N-glycosylation site, which, in concert with another monoclonal antibody to CBG, offered the potential for the determination of intact and total CBG which may both be present in circulation. Here we validate these parallel ELISAs and show that like total CBG there is little diurnal variation of intact plasma CBG. Furthermore in a normal reference population the majority of CBG is in the intact or active form but a significant level of apparently cleaved CBG is evident. In some subjects there is gross discordance between total CBG and intact CBG implying a predominance of apparently cleaved CBG in circulation and this significantly affects calculated free cortisol levels. Gross differences in total and intact CBG levels may not be due to differences in N-glycosylation affecting antibody binding as CBG levels are unaffected by PNGase F treatment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178744     DOI: 10.1016/j.cca.2012.11.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Cortisol stress reactivity in women, diurnal variations, and hormonal contraceptives: studies from the Family Health Patterns Project.

Authors:  William R Lovallo; Andrew J Cohoon; Ashley Acheson; Andrea S Vincent; Kristen H Sorocco
Journal:  Stress       Date:  2019-03-21       Impact factor: 3.493

2.  In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.

Authors:  Ella Rosenne; Liat Sorski; Lee Shaashua; Elad Neeman; Pini Matzner; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2013-12-12       Impact factor: 7.217

3.  The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity.

Authors:  Neta Gotlieb; Ella Rosenne; Pini Matzner; Lee Shaashua; Liat Sorski; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2014-12-26       Impact factor: 7.217

4.  Pyrexia and acidosis act independently of neutrophil elastase reactive center loop cleavage to effect cortisol release from corticosteroid-binding globulin.

Authors:  Emily J Meyer; David J Torpy; Anastasia Chernykh; Morten Thaysen-Andersen; Marni A Nenke; John G Lewis; Harinda Rajapaksha; Wayne Rankin; Steven W Polyak
Journal:  Protein Sci       Date:  2020-11-04       Impact factor: 6.725

5.  Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy.

Authors:  Marni A Nenke; Anna Zeng; Emily J Meyer; John G Lewis; Wayne Rankin; Julie Johnston; Svjetlana Kireta; Shilpanjali Jesudason; David J Torpy
Journal:  J Endocr Soc       Date:  2017-02-13

6.  N-Glycosylation influences human corticosteroid-binding globulin measurements.

Authors:  Lesley A Hill; Zeynep Sumer-Bayraktar; John G Lewis; Eva Morava; Morten Thaysen-Andersen; Geoffrey L Hammond
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

7.  Neutrophil elastase-cleaved corticosteroid-binding globulin is absent in human plasma.

Authors:  Lesley A Hill; Dimitra A Vassiliadi; Ioanna Dimopoulou; Anna J Anderson; Luke D Boyle; Alixe H M Kilgour; Roland H Stimson; Yoan Machado; Christopher M Overall; Brian R Walker; John G Lewis; Geoffrey L Hammond
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.